Meet Medicilon at RACI Congress 2026 - Chemistry & More

We are pleased to announce that Medicilon will attend the RACI Congress 2026 - the flagship event of the Royal Australian Chemical Institute (RACI), bringing together chemical scientists, engineers, and industry leaders from across all RACI chemistry divisions.

July 5-10, 2026
Perth Convention & Exhibition Centre, Perth, Western Australia

Medicilon Booth #9

RACI Congress 2026 is themed “Enabling Innovation in a Carbon Constrained World.” We look forward to showcasing our full-spectrum chemistry R&D platforms - and giving you a glimpse of how our integrated preclinical services can support your program from hit to IND.

Our Experts | Meet our team on site
Jinna Cai - Chief Business Officer

Yongmei Xu - VP of Business Development

Tingshu Wang - Director of Business Development

Highlights Medicilon | Technology Platforms

With 650+ IND approvals supported worldwide (FDA, NMPA, EMA, TGA, MFDS, PMDA), Medicilon provides a full spectrum of drug R&D services under one roof.

Medicinal Chemistry

❖ Focused library construction, activity screening & hit identification

❖ Lead generation, SAR development, lead optimization, PCC selection

 Process Chemistry

❖ Reference scale-up, hundred gram to kilo gram synthesis

❖ Lead/PCC compound scale-up for animal studies

❖ Early stage process study of advanced compounds

Custom Synthesis

❖ Special reagents / intermediates synthesis

❖ Reference / standard synthesis

❖ Special impurities / metabolites synthesis

❖ Stable isotope internal standards synthesis

Technology Platforms

❖ Small molecule, TPD, XDC, RNAi, Peptide, AIDD…

Beyond Chemistry | Let’s Connect!

While our booth focuses on chemistry capabilities, Medicilon also offers biology, PD/PK, CMC, and regulatory support as part of our integrated preclinical CRO services. Come talk to Medicilon team - we’d be happy to discuss how we can support your entire journey from hit to IND, beyond chemistry.See you in Perth!

marketing@medicilon.com 

 www.medicilon.com